Pancreatic Cancer Update: Abandoned Trial, Exciting Research, New AppointmentsAllbiopro2019-07-03T09:49:02+09:007월 3rd, 2019|
Despite Political Rhetoric, Some Drug Prices Jumped on July 1, Including Medicines on Shortage ListsAllbiopro2019-07-03T09:47:13+09:007월 3rd, 2019|
In cybersquatting lawsuit, Adamis says rival Kaléo co-opted its Symjepi trademarkAllbiopro2019-07-03T09:44:30+09:007월 3rd, 2019|
Aurobindo gets warning letter over valsartan recall messAllbiopro2019-07-03T09:43:36+09:007월 3rd, 2019|
Amarin plots salesforce hiring binge to prep for new Vascepa approvalAllbiopro2019-07-03T09:42:43+09:007월 3rd, 2019|
In a crowded psoriasis field, who could nab Celgene’s Otezla—and at what price?Allbiopro2019-07-03T09:41:50+09:007월 3rd, 2019|
GSK taps NASCAR favorite to drive awareness of new Nicorette lozengeAllbiopro2019-07-03T09:40:52+09:007월 3rd, 2019|
Sanofi, Regeneron’s Libtayo hits hot streak with EU green light, NICE backingAllbiopro2019-07-03T09:39:54+09:007월 3rd, 2019|
Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo testAllbiopro2019-07-03T09:38:55+09:007월 3rd, 2019|
CRUK invests in SV fund, pushing it closer to $250M targetAllbiopro2019-07-03T09:37:57+09:007월 3rd, 2019|
After canning clinical pipeline, Merrimack CEO, CFO abandon shipAllbiopro2019-07-03T09:37:00+09:007월 3rd, 2019|
Amicus contracts Thermo Fisher to make Batten disease gene therapyAllbiopro2019-07-03T09:35:07+09:007월 3rd, 2019|
Lonza takes parenteral control through Novartis plant buy and contractAllbiopro2019-07-03T09:34:09+09:007월 3rd, 2019|
